|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Fibromyalgia | |||||
| Fatigue | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Myofascial Pain Syndromes | |||||
| 3 | More general conditions related to this trial | ||||
| Muscular Diseases | |||||
| Musculoskeletal Diseases | |||||
| Nervous System Diseases | |||||
| Neuromuscular Diseases | |||||
| Rheumatic Diseases | |||||
| Signs and Symptoms | |||||
| 4 | Interventions listed in this trial | ||||
| armodafinil | |||||
| Placebo | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Modafinil | |||||
| 6 | More general drug interventions related to this trial | ||||
| Central Nervous System Agents | |||||
| Central Nervous System Stimulants | |||||
| Neuroprotective Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Protective Agents | |||||
| Therapeutic Uses | |||||
| 7 | Sponsors listed in this trial | ||||
| State University of New York - Upstate Medical University | |||||
| Martin Morell MD Arthritis Associates | |||||